Planned Rule 144 share sale in company (Nasdaq: DRTS) disclosed

Rhea-AI Filing Summary

A holder of ordinary shares of issuer DRTS, identified as Raphi Levy, filed a Rule 144 notice to sell 15,000 ordinary shares through Oppenheimer & Co. Inc. on Nasdaq, with an aggregate market value of $106,350.00. The notice states that 70,380,570 ordinary shares were outstanding and that the shares to be sold were originally acquired as 87,500 restricted stock units from the issuer on 08/08/2021.

Over the prior three months, the same seller reported additional sales of ordinary shares: 20,000 shares on 01/08/2026 for gross proceeds of $122,100.00, 10,000 shares on 01/09/2026 for $69,000.00, 10,600 shares on 01/12/2026 for $74,260.00, and 4,400 shares on 01/13/2026 for $31,240.00.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co Inc. 85 Broad St. New York NY 10004	15000	106350.00	70380570	01/13/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	08/08/2021	Restricted Stock Units	Issuer			87500	08/08/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Levy Raphi KIRYAT HAMADA 5 Jerusalem L3 9777605	Ordinary	01/08/2026	20000	122100.00
Levy Raphi KIRYAT HAMADA 5, Jerusalem L3 9777605	Ordinary	01/09/2026	10000	69000.00
Levy Raphi KIRYAT HAMADA 5, Jerusalem L3 9777605	Ordinary	01/12/2026	10600	74260.00
Levy Raphi KIRYAT HAMADA 5, Jerusalem L3 9777605	Ordinary	01/13/2026	4400	31240.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many DRTS shares are planned to be sold under this Form 144?

The notice covers a planned sale of 15,000 ordinary shares of issuer DRTS through Oppenheimer & Co. Inc. on Nasdaq, with an aggregate market value of $106,350.00.

What class of securities is being sold for DRTS and on which exchange?

The planned transaction involves ordinary shares of issuer DRTS, to be sold through Oppenheimer & Co. Inc. on the Nasdaq exchange.

When and how were the DRTS securities being sold originally acquired?

The securities were acquired on 08/08/2021 as restricted stock units from the issuer, in an amount of 87,500 units, with the payment nature listed as N/A.

How many DRTS shares are outstanding according to this Form 144?

The filing reports that 70,380,570 ordinary shares of issuer DRTS were outstanding at the time referenced in the notice.

What DRTS share sales has the filer reported in the past three months?

The filer reported prior sales of DRTS ordinary shares during the past three months: 20,000 shares on 01/08/2026 for $122,100.00, 10,000 shares on 01/09/2026 for $69,000.00, 10,600 shares on 01/12/2026 for $74,260.00, and 4,400 shares on 01/13/2026 for $31,240.00.

Who is the selling security holder in this DRTS Rule 144 notice?

The selling security holder is identified as Levy Raphi, with an address at KIRYAT HAMADA 5, Jerusalem, L3 9777605, as shown in the section on securities sold during the past three months.